Agenda - FDA Public Meeting on Safety Issues Associated with Dietary Supplement Use During Pregnancy

Side Navigational Buttons

Agenda

FDA Public Meeting on Safety Issues Associated
with Dietary Supplement Use During Pregnancy

Crystal Ballroom - Gaithersburg Hilton
620 Perry Parkway
Gaithersburg, MD 20877
March 30, 2000, 9:00 A.M. - 5:00 P.M.

FDA Panel Members: Bernard Schwetz, Janet Woodcock, Joe Levitt, Louisa Nickerson, Margaret Dotzel, Michael Greene, Bonnie Lee

Morning Public Panel Members: William Soller, Juliette Kendrick, Michael McGuffin, Annette Dickinson, Donald Mattison, Josef Brinckmann, Jan Friedman

Afternoon Public Panel Members: Sidney Wolfe, Susan Panney, Allen Mitchell, David Erickson, Marietta Anthony, Godfrey Oakley

9:00 a.m. Administrative Announcements: Rose Cunningham

Opening Remarks and Introductions: Bern Schwetz

Overview of Legal Background: Louisa Nickerson

9:30 a.m. Morning Public Panel Presentations:

Dr. R. William Soller, Sr. Vice President Consumer Healthcare Products Association (20 minutes)

Juliette S. Kendrick, Medical Epidemiologist, Centers for Disease Control and Prevention (15 minutes)

Michael McGuffin, President American Herbal Products Association (10 minutes)

Questions from FDA Panel

Discussion from floor (if time permits)

10:45 a.m. BREAK

11:00 a.m. Continuation of Morning Public Panel Presentations:

Annette Dickinson, Vice President for Scientific and Regulatory Affairs, The Council for Responsible Nutrition (15 minutes)

Donald R. Mattison, MD, Medical Director, March of Dimes Birth Defects Foundation (10 minutes)

Joseph A. Brinckmann, Research and Development Manager, Traditional Medicinals. (10 minutes)

Jan M. Friedman, Professior, Medical Genetics, University of British Columbia (15 minutes)

Questions from FDA Panel

Discussion from floor (if time permits)

12:15 p.m. LUNCH

1:15 p.m. Introduction of Afternoon Public Panel Members - Bern Schwetz

1:30 p.m. Afternoon Public Panel Presentations:

Sidney M. Wolfe, M.D., Director, Public Citizen’s Health Research Group (10 minutes)

Dr. Susan Panny, for American Academy of Pediatrics (15 minutes)

Allen A. Mitchell, Director, Slone Epidemiology Unit (10 minutes)

Questions from FDA Panel

Discussion from floor (if time permits)

2:45 p.m. BREAK

3:00 p.m. Continuation of Afternoon Public Panel Presentations:

Dr. J. David Erickson, Centers for Disease Control and Prevention (10 minutes)

Marietta Anthony, Director of Women’s Health, Department of Pharmacology, Georgetown University (15 minutes)

Godfrey P. Oakley, Jr., M.D., M.S.P.M., Visiting Professor, Epidemiology, Rollins School of Public Health of Emory University (10 minutes)

Questions from FDA Panel

Discussion from floor (if time permits)

4:30 p.m. Open Discussion to Audience (if time permits)

FDA/Center for Drug Evaluation and Research
Last Updated: March 08, 2001
Originator: OTCOM/DML
HTML by GYC